Cumberland Pharmaceuticals has recently received approval from the US FDA for its RediTrex injection for the treatment of rheumatoid arthritis. Cumberland pharmaceuticals pharma company focusing on...
Geographic atrophy (GA) is a severe, progressive, irreversible vision loss in old age people. The loss in the vision is due to the damage in a small portion of the retina at the back of the eye, known as the macula. Since the loss of vision is due to age, it is also referred to as Age-related macular degeneration. ...
Find More
Boehringer Ingelheim and Inflammasome Therapeutics Inc. have announced that they have entered into a definitive a co-development and license agreement to develop therapies for the patients with retinal diseases.The deal is about jointly developing three novel therapies for retinal diseases with the help of Inflamma...
Find More
Daiichi Sankyo announced the submission of a New Drug Application (NDA) of DS-8201 to Japan's Ministry of Health, Labour and Welfare (MHLW). DS-8201 [fam-] trastuzumab deruxtecan), is an investigational antibody-drug conjugate (ADC) designed to deliver cytotoxic chemotherapy to cancer cells via a human epiderma...
Find More
Vertex Pharmaceuticals recently has announced the acquisition of Semma Therapeutics for USD 950 million in cash. Vertex Pharmaceuticals, aimed at creating therapies for life-threatening diseases, like cystic fibrosis, has signed a definitive agreement with Semma therapeutics, working to bring in the Healthcare ...
Find More
More than 50 million Americans suffer from allergies each year. They are the 6th leading cause of chronic illness in the U.S. with an annual expenditure of USD 18 Billion. For some allergies mean constant sniffle, sneeze or cough due to occasional weather change, dust or air, whereas for others it can be due to kno...
Find More
Leber Hereditary Optic Neuropathy (LHON) is a significant contributing factor behind the increasing blindness burden among young population. The birth LHON prevalence is approximately 1 in 50,000 people as estimated by the Rare Disease Database. Leber Hereditary Optic Neuropathy is a common inherited condition c...
Find More
Cataract A cataract is a clouding of the lens in the eye that affects vision. Most cataracts are related to ageing. Cataracts are very common in older people. A cataract can occur in either or both eyes. It cannot spread from one eye to the other. June is the month of Cataract Awareness Month, and the sole a...
Find More
AstraZeneca-Daiichi breast cancer treatment scored promising results The breast cancer drug trastuzumab deruxtecan developed by AstraZeneca and Daiichi Sankyo showed positive results in a metastatic breast cancer trial. AstraZeneca remunerated Daiichi Sankyo USD 1.35 billion upfront and guaranteed up to USD 6.9 ...
Find More
The Cornea- the outermost layer in the human eye, plays an important role in regulating the amount of light entering into the eye. It also protects the eye from germs, dust, and other harmful matter. Although this important part of the human body has a countless number of ways to get damaged. Corneal Abrasions, Dry...
Find More
A formal medical disorder affecting approximately 10 percent of the world population is trypanophobi.....
Find More
Osteosarcoma is a kind of bone cancer that originates from the cells that form bones. It is often fo.....
Find More
Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of.....
Find More
Rheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that leads to progressive an.....
Find More
A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS), affects 1 in 1 to 2 mi.....
Find More
Autoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfun.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
